Clinical Trial Update: Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessed the safety, tolerability, immunogenicity, and pharmacokinetics of MEDI-528 in healthy adult volunteers; the study was complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI-528

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2014-03-06